Structure
Volume 2, Issue 9, September 1994, Pages 853-868
Journal home page for Structure

Research Article
High-resolution solution structures of oxidized and reduced Escherichia coli thioredoxin

https://doi.org/10.1016/S0969-2126(94)00086-7Get rights and content
Under a Creative Commons license
open archive

Abstract

Background Thioredoxin participates in thiol–disulfide exchange reactions and both oxidized thio redoxin (disulfide form) and reduced thioredoxin (dithiol form) are foundunder physiological conditions. Previous structural studies suggested that the two forms were extremely similar, although significant functional and spectroscopic differences exist. We therefore undertook high-resolution solution structural studies of the two forms of Escherichia coli thioredoxin in order to detect subtle conformational differences.

Results The solution structures of reduced and oxidized thioredoxin are extremely similar. Backbone structure is largely identical in the two forms, with slight differences in the region of the active site, which includes Cys32 and Cys35. The side chain sulfur atom of Cys32 is tilted away from that of Cys35 in the reduced form of the protein to accommodate the increase in S–S distance that occurs upon reduction of the disulfide, but the χ1 angles of the two cysteines remain the same in the two forms.

Conclusions Only subtle conformational changes occur upon changing the oxidation state of the active site cysteines, including the positions of some side chains and in hydrogen bonding patterns in the active site region. Functional differences between the two forms are probably therefore related to differences in local conformational flexibility in and near the active site loop.

Keywords

NMR
solution structure
thiol-disulfide
thioredoxin

Cited by (0)

Mei–Fen Jeng, A Patricia, Campbell, David A Case, Peter E Wright, H Jane Dyson (corresponding address), Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA92037, USA.

Tadhg Begley, Department of Chemistry, Cornell University, Ithaca, New York, USA.

Arne Holmgren, Department of Biochemistry, Karolinska Institute, Stockholm, Sweden.